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to symptom awareness [n = 21], lack of symp-
tom awareness measured outcomes [n = 6], dis-
sertations [n = 2] or unrepresentative of general 
female populations [n = 2]). Reference lists 
from included articles and review articles were 
also reviewed for relevant papers, with 13 extra 
papers retrieved. These 106 full papers were then 
reviewed. Of these, 52 are included in this review. 
Those excluded from the review did not report 
measures on symptom awareness, were qualita-
tive, did not report data separately for females, 
discussed treatment delay rather than delay in 
help-seeking, were datasets previously reported 
or discussed symptom experience rather than 
awareness.
Papers were included that quantified women’s 
knowledge of cancer symptoms, the factors asso-
ciated with this knowledge, behavioral responses 
to potential symptoms and discussed factors 
associated with intending to or actually seeking 
help for cancer symptoms. Qualitative studies 
were excluded from the review. Where studies 
included male and female respondents, only the 
data from female respondents are included in 
this paper.
A number of papers were retrieved from non-
western nations. These papers were included as 
the high levels of immigration into western devel-
oped countries means that awareness of immi-
grant women about cancer symptoms and issues 
surrounding help-seeking behaviors is particu-
larly important for health service agencies that 
aspire to ensure equality in health across popula-
tions. For practical reasons, only papers written 
in English were included in the review.
The paper commences with an overview of 
the small number of studies that have addressed 
women’s awareness of a variety of cancer symp-
toms across all forms of cancer, followed by a 
While women’s decision to seek diagnosis and 
treatment for cancer are influenced by a complex 
interaction of demographic, clinical, cognitive, 
behavioral and social factors [1], awareness of 
symptoms is an important precursor to action. 
Poor awareness of cancer symptoms (i.e., not 
recognizing that the symptoms may represent a 
significant medical condition [2] – in this case, 
cancer) has been associated with patient delay in 
help-seeking; late diagnosis, in turn, is associated 
with reduced survival, the need for more aggressive 
treatment and fewer treatment choices [2–4].
The purpose of this current review is to exam-
ine the evidence on women’s awareness of can-
cer symptoms – to identify knowledge gaps and 
misperceptions and, thus, improve help-seeking 
behaviors (e.g., attending a medical practitioner 
for investigation of potential symptoms) at the 
early stages of disease.
Methods
The databases MEDLINE, ProQuest, Scopus, 
Web of Knowledge, Health Reference Centre, 
Informit and PsycINFO were searched using the 
following keywords: ‘cancer’ AND ‘knowledge’ 
OR ‘awareness’ OR ‘understanding’ AND ‘symp-
toms’ AND ‘women’. An additional search using 
the keywords ‘cancer’ AND ‘help-seeking’ OR 
‘delay’ was also conducted. Literature was lim-
ited to English language, peer-reviewed journal 
articles from the year 2000 onwards. The search 
was conducted with a view to achieving a high 
sensitivity but low specificity, retrieving a high 
number of articles (n = 1332 titles retrieved). 
Titles were scanned to exclude content not rel-
evant to cancer symptoms (reduced to 187 arti-
cles) and then abstracts reviewed with a further 
94 papers excluded (review articles [n = 18], 
qualitative research [n = 42], content not specific 
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review of the literature on female cancers (breast 
then gynecological, then colorectal cancer). 
For each cancer type, the included papers are 
reviewed for: country of study, study method, 
population/sampling frame (e.g., general popula-
tion, screening clinic attendees, cancer patients), 
sampling (e.g., method, sample size and response 
rate) and findings on symptom awareness.
The paper finishes with a summary of what is 
known, what the gaps are in the literature and 
recommendations for research and practice.
‘Cancer symptom’ awareness
Four studies were identified that assessed wom-
en’s awareness of cancer symptoms across all 
sites (all four studies included male and female 
respondents; only the data from female respon-
dents are reported) three studies were from 
the UK [5–7] (note that Waller reports on the 
same dataset as Brunswick) and one from the 
Netherlands [8]. Two of the studies used recall 
(i.e., open-ended questions that asked women 
to name symptoms), whereas the other two used 
recognition (i.e., asking women to state whether 
they believed each of a list of items to be potential 
symptoms of cancer).
The first of the two ‘symptom recognition’ 
studies was conducted in the UK with a stratified 
probability sample that included 1854 women, 
with a response rate of 69% [5]; the second study 
was conducted in the Netherlands with a conven-
ience sample of respondents to newspaper adver-
tisements that included 1221 women with a mean 
age of 46 years [8]. When provided with a list 
of symptoms, the majority of the British [5] and 
Dutch respondents [8], respectively, recognized as 
‘warning signs’ or symptoms of cancer: thicken-
ing/lump (84.0 and 56.0%); change in a mole or 
wart (79.0 and 82.3%); bleeding/discharge (74.3 
and 62.6%; described as ‘unusual’ bleeding or 
discharge in the Dutch study); change in bowel 
or bladder habits (73.7%; separated in the Dutch 
study into bowel [44.6%] and urinary [32.0%]); 
and persistent cough or hoarseness (53.8 and 
55.0%). Less than half responded affirmatively 
to a sore that does not heal (47.3 and 39.0%) and 
indigestion or difficulty swallowing (37.7 and 
42.4%). Recognition of symptoms only included 
in the Dutch study was 61.9% for unusual weight 
loss and 58.8% for new warts.
The two recall studies were conducted in 
the UK with stratified probability samples 
that included 874 women aged 16–75 years [6], 
and 1240 women ranging from 16 years and 
over 65 years [7]. As expected, recall of symp-
toms was lower than recognition (note that 
the second paper did not report exact figures). 
Approximately three-quarters of women spon-
taneously mentioned thickening or a lump, less 
than half mentioned bleeding or discharge, less 
than one-third mentioned a change in a mole or 
wart or unusual weight loss, less than one-fifth 
mentioned a change in bowel or bladder habits 
or persistent cough or hoarseness, and less than 
one-tenth mentioned indigestion or difficulty 
swallowing or a sore that does not heal.
Higher levels of symptom awareness were 
associated with being older [5–7], having a higher 
level of education [5,6,8], higher socioeconomic 
status or income [5,7], being married [7] and being 
Caucasian [7].
Breast cancer
Breast cancer is the most commonly diagnosed 
cancer in women (excluding skin); accounting 
for 31% of diagnoses in the UK [9], 29% in the 
USA [10] and 30% in Australia (the Australian 
Institute of Health and Welfare report includes 
skin cancer; the figures were recalculated by 
the authors excluding skin cancer to enable 
comparison with the UK and US data) [11].
Thirty six articles were identif ied that 
addressed women’s awareness of breast cancer 
symptoms: the majority were from the UK (ten in 
total), with four from the USA [12–15], three each 
from Malaysia [16–18] and Iran [19–21], two each 
from the Republic of Ireland [22,23], India [24,25] 
and Nigeria [26,27], and one each from Canada 
[28], Australia [29], New Zealand [30], Germany 
[31], Singapore [32], Sierra Leone [33], Nepal [34], 
Turkey [35], Pakistan [36] and Myanmar [37].
Nineteen of the articles reported on surveys 
of asymptomatic women in the general popu-
lation who were not undergoing cancer treat-
ment, screening or education; an additional 
three articles reported on surveys of university 
students [16,18,27]. Among the 19 general popula-
tion surveys (Table 1), sample sizes ranged from 
50 [28] to 3005 [29], and response rates, for the 
ten which reported this data, ranged from 32 [29] 
to 92% [14].
The majority of these studies targeted the 
female population as a whole and, thus, gener-
ally experienced the same limitations of gener-
alizability, including under-representing women 
from minority groups and those with lower levels 
of education. However, this was addressed in a 
UK study, which stratified sampling by tertiles 
of deprivation and oversampled nonwhite eth-
nic groups [38]; a UK study, which oversampled 
for black and minority ethnic groups [39]; and 
an Indian study, which recruited a sample that 
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included 46% of respondents who were illiter-
ate [25]. A further three studies sought specifi-
cally to explore cancer awareness among minor-
ity groups: Chinese–American women living 
in Chicago in the USA [15]; Tongan–American 
women in California in the USA [14]; and Iranian 
immigrant women in Toronto, Canada [28]. All 
but two of the surveys were conducted with the 
aim of exploring women’s general knowledge and 
beliefs regarding breast cancer symptoms and 
screening; these two studies sought to examine 
potential predictors of delay in seeking diagnosis 
and treatment (note that Grunfeld et al. reports 
on the same dataset) [12,40].
Twelve articles reported on surveys conducted 
with women who were diagnosed with breast 
cancer [13,31,41,42], attending for follow-up of 
symptoms [23,30,43,44], attending for breast screen-
ing [45,46] or attending a breast cancer educational 
program or information session (Table 2) [33,35]. 
Table 1. General population surveys: breast cancer.
Author (year) Country Sample size Sampling 
method
Survey method Age range 
(mean; years)
Response 
rate (%)
Ref.
Jones et al. (2010) Australia 3005 Stratified random CATI 30–69 (50) 32 [29]
Grunfeld et al. 
(2002)
UK 1830 Random 
representative 
Face-to-face and phone 16–96 (47) 67 [47]
Linsell et al. 
(2008)
UK 712 Random 
representative 
Postal 67–73 (N/S) 84 [48]
McMenamin et al. 
(2005)
Ireland 1250 Convenience 
(intercept)
Self-completed 16–50+ (N/S) N/S [22]
Forbes et al. 
(2011)
UK 1515 Stratified random Face-to-face 
(researcher-completed)
30–65+ (N/S) 81 [38]
Facione et al. 
(2002)
USA 699 Convenience Self-completed 19–99 (47) N/S [12]
Scanlon and 
Wood (2005)
UK 342 (general)
676 (BME)
Representative, 
with quotas for 
seven BME groups
Phone (general) and 
face-to-face (BME)
18+ (N/S) N/S [39]
Yu et al. (2001) USA 332 Purposive Face-to-face 
(researcher-completed)
40–69 (54) N/S [15]
Tanjasiri et al. 
(2002)
USA 303 Convenience Face-to-face 
(researcher-completed)
40–60+ (N/S) 92 [14]
Vahabi (2011) Canada 50 Convenience Face-to-face 
(researcher-completed)
29–66 (45) 80 [28]
Baig et al. (2011) Malaysia 320 Random Face-to-face 
(researcher-completed)
16–55 (27) 80 [17]
Somdatta and 
Baridalyne (2008)
India 333 Random Face-to-face 
(researcher-completed)
16–80+ (36) N/S [25]
Okobia et al. 
(2006)
Nigeria 1000 Random Face-to-face 
(researcher-completed)
15–91 (29) N/A† [26]
Montazeri et al. 
(2008)
Iran 1402 Cluster randomized Face-to-face 
(researcher-completed)
20–80 (43) N/S [20]
Sim et al. (2009) Singapore 1000 Convenience 
(intercept)
Self-completed <30–60+ (N/S) N/S [32]
Grunfeld and 
Kohli (2010)
India 685 Convenience 
(intercept)
Researcher-completed 
or self-completed
16–84 (49) 86 [24]
Bhatt et al. (2011) Nepal 100 Convenience Face-to-face 
(researcher-completed)
19–65 (37) N/S [34]
Hunter et al. 
(2003)
UK 546 Purposive (from 
random)
Postal 16–86 (47) 70 [40]
Mon et al. (2009) Myanmar 400 N/S N/S 40–60+ (48) N/S [37]
†Replacement for nonresponse.
BME: Black and minority ethnic; CATI: Computer-assisted telephone interview; N/A: Not applicable; N/S: Not stated.
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Sample sizes ranged from 69 [41] to 867 women 
[46]. Few of these articles reported response rates; 
those that did suggested that relatively higher 
response rates were achieved than with general 
population surveys, ranging from 59 [35] to 98% 
[43]. The four studies that were conducted with 
women diagnosed with breast cancer aimed to 
identify the predictors of delay in seeking diag-
nosis and treatment, as did three of the studies 
conducted with women presenting for investiga-
tion of symptoms [23,30,43]. The four studies con-
ducted with women attending breast screening or 
information sessions were designed to assess the 
effectiveness of breast cancer education sessions.
Awareness of symptoms
While the studies included in this review dif-
fered in their methodologies, scope and, in 
some cases, purpose, the majority asked women 
to name potential symptoms of breast cancer. 
Again, it is important to note that some studies 
used recall while others used recognition.
The UK National Health Service (NHS) rec-
ommends that women see their family doctor if 
they notice any of the following:
•	 A lump or area of thickened tissue in either 
breast;
•	 A change in the size or shape of one, or both, 
breasts;
•	 A discharge from either nipple (which may be 
streaked with blood);
•	 A lump or swelling in either armpit;
•	 A dimpling on the skin of the breast;
•	 A rash on or around the nipple;
•	 A change in the appearance of the nipple, such 
as becoming sunken into the breast;
•	 Pain in either breast or armpit that is not 
related to the menstrual period [101].
Table 2. Surveys conducted in healthcare settings: breast cancer.
Author (year) Country Sample Sample 
size
Survey method Age range 
(mean; years)
Ref.
Pullyblank et al. 
(2002)
UK Attending breast clinic 75 Researcher-administered, self-completed N/S (46) [44]
Linsell et al. 
(2009)
UK Attending routine breast 
screening
867 Researcher-administered, self-completed 67–70 (N/S) [46]
Burgess et al. 
(2008)
UK Attending routine breast 
screening
292 Postal N/S [45]
Meechan et al. 
(2003)
New 
Zealand
Self-discovered breast 
symptoms referred 
to clinic
85 Nurse-administered, self-completed 
questionnaire followed by face-to-face 
interview with researcher
20–71 (39) [30]
O’Mahony and 
Hegarty (2009)
Ireland Self-discovered breast 
symptoms referred 
to clinic
99 Researcher-administered, self-completed 18–75 (40) [23]
Nosarti et al. 
(2000)
UK Referred to breast clinic 692 Face-to-face semistructured interview 40–75 (N/S) [43]
Arndt et al. 
(2002)
Germany Diagnosed with 
breast cancer
287 Face-to-face, researcher-completed 18–80 (57) [31]
Burgess et al. 
(2006)
UK Diagnosed with 
breast cancer 
69 Face-to-face semistructured interview 65–96 (78) [41]
Rauscher et al. 
(2010)
USA Diagnosed with 
breast cancer 
438 Face-to-face, researcher-completed 30–79 (N/S) [13]
Budakoglu et al. 
(2007)
Turkey Attending breast cancer 
education
462 Self-completed questionnaire and 
face-to-face interviews
40–80 (48) [35]
Shepherd and 
McInerney 
(2006)
Sierra 
Leone
Attending breast cancer 
education
120 Face-to-face, researcher-completed 18–50+ (N/S) [33]
Harirchii et al. 
(2005)
Iran Advanced breast cancer 200 Face-to-face, researcher-completed 20–79 (47) [19]
N/S: Not stated.
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This list of symptoms is largely consistent with 
those of other national health authorities, albeit 
with some differences in wording. For example, 
the US National Cancer Institute combines 
the breast and armpit in a single descriptor, “A 
lump or thickening in or near the breast or in 
the underarm area” and refers to “dimpling or 
puckering in the skin of the breast” [102]. Perhaps 
the most notable difference is the inclusion of 
pain as a symptom in the UK NHS list (but 
not that of Cancer Research UK [103], the US 
National Cancer Institute [102] or the Canadian 
Cancer Society [104]); in Australia this is typically 
described as “an unusual pain that does not go 
away” [105].
Given that the majority of breast cancer aware-
ness survey studies identified in this review were 
conducted in the UK, the UK NHS list of symp-
toms has been used as the organizing structure for 
the reporting of findings on symptom awareness.
Many of the studies did not report levels of 
awareness of individual symptoms, rather they 
reported on specific symptoms of interest to the 
researchers or on the number of symptoms iden-
tified. A UK study reported that only 18% of 
respondents recognized five or more nonlump 
symptoms of cancer from a list [38]; a US study 
found that 14% of respondents identified only 
a ‘lump’ as a symptom and only 10% identified 
all, or all but one, of the 15 symptoms correctly 
[12]; a UK study reported that at baseline, 42% 
could circle five symptoms or more from a list 
of 11 [46]; and another UK study found that the 
mean number of symptoms recognized from a 
list of 11 was 5.3 [45].
Eleven of the articles reported data for some or 
all of the listed symptoms in terms of the propor-
tion of respondents who recalled or recognized 
these as potential symptoms of breast cancer 
(Table 3). It is clear that a breast lump is the most 
consistently identified symptom of breast cancer, 
with high levels of both recognition and recall 
(particularly in western countries). Other symp-
toms, such as a lump or swelling in the armpit, 
discharge from the nipple or a change in the size 
or shape of the breast, are recognized but not 
recalled (i.e., the majority of women agree when 
they are presented with a written list and asked 
whether these are symptoms, but do not spon-
taneously think of them when asked to name 
possible symptoms). A third group of symp-
toms, which includes dimpling of the skin and 
inversion of the nipple, are neither recalled nor 
recognized by the majority of women.
It is interesting to note the high ‘recognition’ 
of pain as a symptom of breast cancer, despite 
the absence of pain as a potential symptom in the 
materials developed and disseminated by many 
of the major cancer agencies as detailed previ-
ously. Among the studies described in this table, 
pain was recognized or recalled as a symptom 
of breast cancer by large proportions of respon-
dents (often more than half). Similarly, 72% of 
a sample of Iranian women living in Canada [28] 
and 52% of Singaporean women [32] associated 
breast pain with early breast cancer.
Predictors of awareness
A number of demographic factors are consis-
tently found to be associated with breast can-
cer awareness and, particularly, knowledge of 
symptoms and screening. Older respondents 
identify fewer symptoms [32,47] and hold more 
mis conceptions about breast cancer [13]. Perhaps 
the biggest predictor is education, with studies 
consistently finding an association between 
increased education level and increased aware-
ness of cancer symptoms [13,17,26,32,34,48]. For 
example, in a UK study, women with O-level 
qualification or above (ordinary [O] level is a 
standard qualification in the UK, usually taken 
at age 15–16 years), identified a median of seven 
symptoms compared with a median of five for 
women with no educational qualifications [48]; 
and in a US study women with some college 
education identified a mean of ten symptoms, 
compared with seven for those with only high-
school completion and six for those with lower 
education [12]. Consistent with this, those in 
lower-skilled employment report lower can-
cer awareness [26,34,47], as do those with lower 
incomes [13,32].
Being part of an ethnic minority, or being a 
non-native language speaker, is associated with 
lower awareness of breast cancer symptoms. For 
example, a UK study found that south-Asian 
women were significantly less likely to recog-
nize five or more symptoms (9.6%) than black 
women (15.9%), and both groups were less 
likely to do so than white women (22.1%) [38]; 
a US study found that African–Americans and 
Hispanics are significantly more likely to hold 
mis conceptions about cancer than are white 
Americans (18 and 35% compared with 5%) 
[13]. This is even more evident when compar-
ing between, rather than within, studies. For 
example, a survey of Iranians living in Canada 
reported that the majority did not know what 
symptoms to look for (data not provided) [28]; 
a survey of Chinese immigrants in Chicago 
found that, unprompted, 65% could not iden-
tify a single cancer symptom [15]; and a UK study 
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reported that 38% of black and minority eth-
nic respondents stated that a lump is the only 
symptom, compared with 22% of the general 
population [38].
Studies from non-English speaking coun-
tries, and with rural populations, also found 
low levels of symptom awareness. For example, 
Indian respondents identified an average of three 
symptoms from a list of eight (and four distrac-
tors), with rural respondents being less likely to 
correctly identify symptoms [24]; only 42% of 
women attending a breast information session 
in Sierra Leone could name some symptoms [33]; 
and only 21.4% of a Nigerian sample were aware 
that breast cancer presents most commonly as a 
painless lump, with even fewer responding cor-
rectly to questions on other symptoms, including 
ulceration of the nipple (data not provided) [26].
Other factors found to be associated with 
breast cancer awareness include prior exposure 
to breast cancer via a family member or friend 
[32,44] and prior interactions with medical ser-
vices. For example, in US studies, symptom 
awareness has been found to be associated with 
prior clinical breast examination or mammo-
gram [14], although the direction of this relation-
ship is unclear (i.e., it may be that awareness of 
symptoms increases the likelihood of screening, 
or that information provided by health profes-
sionals during screening increases symptom 
awareness), misconceptions about cancer have 
also been found to be associated with a lack of 
private health insurance and not having a regular 
doctor [13]. Similarly, in a Nepalese study, knowl-
edge was related to prior discussions about breast 
cancer during clinic visits [34].
Gynecological cancers
While considered separately, each of the gyne-
cological cancers is not in the top three cancers 
Table 3. Recall and recognition of specific symptoms: breast cancer.
Author 
(year)
Country Method Breast 
lump/
thickening 
(%)
Change 
in size/
shape 
(%)
Nipple 
discharge 
(%)
Armpit 
lump/
swelling 
(%)
Dimpling 
skin (%)
Rash 
(%) 
Inversion 
of nipple 
(%)
Pain 
in 
breast 
(%)
NIL 
(%)
Ref.
Grunfeld 
et al. (2002)
UK Recognition 85 64 70 80 39 – 38 50 – [47]
Linsell et al. 
(2008)
UK Recognition 93 67 72 86 57 14 60 53 – [48]
Tanjasiri 
et al. (2002)
USA Recognition 88 32 50 – 31 – – 86 – [14]
Montazeri 
et al. (2008)
Iran Recognition 44 2 6–8 – – – 5 16 6 [20]
Akhtari-
Zavare et al. 
(2011)
Malaysia Recognition 62 63† 60 – – – 64 – – [16]
Hadi et al. 
(2010)
Malaysia Recognition 72 82 75 79 59 – – 79 – [18]
Jones et al. 
(2010)
Australia Recall 86 16 34 6 17 – – 25 5 [29]
McMenamin 
et al. (2005)
Ireland Recall 74 – 6 – – – – 14 24 [22]
Pullyblank 
et al. (2002)
UK Recall 75 – 48 – – – – – – [44]
Budakoglu 
et al. (2007)
Turkey Recall 67 – 12 – 2 – 4 40 – [35]
Somdatta 
and 
Baridalyne 
(2008)
India Recall 42‡ – 7 – 1.6 – – 41 49 [25]
†Described as ‘swelling of all or part of the breast’.
‡Only 5% knew that painless lump is a symptom of breast cancer. Other symptoms identified were fever, itching, weight loss, breast abscess and presence of 
breast ulcer. 
NIL: None. 
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in most countries, but when combined they 
account for more cases of cancer in women 
than colorectal cancer. For example, uterine 
and ovarian cancer are the fourth and fifth most 
commonly diagnosed cancers in women in the 
UK [9] and the fifth and eighth in Australia 
[11]. In the USA, it is estimated that there will 
be 88,750 new cases of gynecological cancers 
in 2012 (including uterine, ovarian, cervical, 
vulval, vaginal and other genital) [10].
Eight articles were identified that addressed 
women’s awareness of gynecological cancer 
symptoms: three related to ovarian cancer [49–51]; 
two to cervical cancer [52,53]; one to endometrial 
cancer [54]; one to gynecological cancers in gen-
eral [55]; and one to common female cancers (also 
discussed above regarding breast cancer) [37].
Five of the articles reported on population 
based surveys of cancer awareness among women 
without a cancer diagnosis; two from the USA 
[51,55] and one each from Australia [50], Myanmar 
[37] and Laos [53]. Sample sizes ranged from 400 
[37] to 2991 [55]; response rates were not provided 
for the majority of studies (Table 4).
Both of the ovarian cancer surveys asked 
women whether a series of symptoms were 
potentially those of ovarian cancer, with six 
symptoms included in both studies. Weight 
changes – described as ‘putting on weight 
around the middle’ in the Australian study 
and ‘unexplained weight gain or loss’ in the US 
study – was recognized as a symptom by 30.6% 
of the Australian sample [50] and 35.9% of the 
US sample [51]; feeling full or bloated by 58.6% 
of the Australian and 47.2% of the US samples; 
and tiredness/ongoing unusual fatigue by 73.3% 
of the Australian and 35.8% of the US samples. 
Among the Australian sample, indigestion was 
recognized as a potential symptom by 17.7% and 
nausea by 68.9%; in the US study these were 
combined as ‘vague or persistent gastrointestinal 
upsets such as gas, nausea and indigestion’ and 
were recognized as a symptom by 29.2%. Levels 
of agreement with other symptoms asked in the 
Australian study were stomach pain (82.3%), 
changes in the menstrual cycle (91.6%) and 
backache (76.9%), and in the US study, fre-
quency and/or urgency in urination (26.3%). To 
control for affirmative response bias (i.e., ticking 
yes to all items), both studies included items that 
were not potential symptoms of ovarian cancer. 
Levels of agreement that these were ovarian 
cancer symptoms in the Australian study were 
31.0% for headache and 10.5% for chest pain, 
and 17.5% for continuous fever in the US study.
The other US study, which addressed gyne-
cologic cancers more generally [55], did not ask 
about awareness of symptoms, but rather inten-
tion to seek help if experiencing specific symp-
toms. Women were more likely to report intend-
ing to seek help for postmenopausal bleeding 
(90.5%), vaginal itching (90.4%) and vaginal 
discharge (83.1%) than for bloating (41.0%) 
or feeling full after eating a small amount of 
food (37.2%).
The Laos study assessed awareness of cer-
vical cancer symptoms; the Myanmar study 
included similar symptoms. Of the four symp-
toms included in both studies, abnormal vagi-
nal bleeding was recognized as a symptom by 
76.3% of respondents in Myanamar and 52% 
in Laos; bleeding after coitus by 42.1% in 
Myanmar and 33% in Laos; and vaginal dis-
charge by 63.3% in Myanmar (question referred 
Table 4. General population surveys: gynecological cancer.
Author (year) Country Sample 
size
Sampling 
method
Survey method Age range 
(mean; years)
Response 
rate (%)
Cancer type(s) Ref.
Jones et al. (2010) Australia 2954 Stratified 
random
CATI 30–69 (48) 32% Ovarian [50]
Lockwood-
Rayerman et al.
(2009)
USA 1211 Random 
(from panel)
Email 40–60+ (N/S) N/S† Ovarian [51]
Trivers et al. (2011) USA 2991 Stratified 
random
Mail 18–50+ (N/S) 77.1 Gynecologic [55]
Mon et al. (2009) Myanmar 400 N/S N/S 40–60+ (48) N/S Common female 
cancers
[37]
Phongsavan et al. 
(2010)
Laos 800 Purposive Face-to-face 
(interviewer-
completed)
18–55 (34) N/S Cervical [53]
†States that panel has approximately 1 million members, first 1235 were used.
CATI: Computer-assisted telephone interview; N/S: Not stated.
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to ‘white’ discharge) and 64% in Laos (question 
referred to ‘foul’ discharge). Dsypareunia was 
recognized as a potential symptom by 43.5% 
of respondents in the Myanmar survey and 
menorrhagia by 34% in the Laos survey.
Given the small number of studies, and that 
few of these reported on predictors/correlates 
of awareness, it is difficult to draw any conclu-
sions about factors associated with awareness. 
The Australian study found that older women 
generally had lower levels of awareness of ovar-
ian cancer symptoms [50], but the US awareness 
study found no differences by age or ethnicity, 
but (consistent with the breast cancer aware-
ness research) found an association between 
awareness and education level [51]. The US 
help-seeking intention study found that older 
women were more likely to seek medical care for 
symptoms, as were black and Hispanic women 
and women with greater concern about getting 
gynecological cancer [55]. They found no dif-
ferences in intentions by income, education, 
employment status or marital status.
Three studies sought to explore reasons for 
delayed diagnosis and, of relevance to this 
review, associations between symptom aware-
ness and delays in seeking treatment; these 
included a UK study with endometrial can-
cer patients in hospitals (mean age: 68 years )
[54]; a Canadian study with subscribers to an 
ovarian cancer patient newsletter (mean age: 
52 years) [49]; and a Tanzanian study with hos-
pital patients with cervical cancer (mean age: 
49 years) and/or ‘other gynecological problems’ 
(mean age: 46 years) [52]. (A fourth study, con-
ducted in Hong Kong with newly diagnosed 
ovarian cancer patients [Chan et al. [56]] was 
excluded as the lack of data provided in the 
article prevented interpretation of the find-
ings.) Sample sizes in these studies ranged from 
123 [54] to 1725 patients [49].
The endometrial cancer study found that 41 
of the 85 women who reported having expe-
rienced abnormal uterine bleeding said they 
had no idea it was a sign of possible cancer; 
half waited more than a month before seeing 
their general practitioner and 12% waited more 
than 6 months [54]. The ovarian cancer study 
did not specifically address awareness of symp-
toms; however, 22% of respondents stated that 
they had ‘ignored’ their symptoms, suggest-
ing that they were not aware that these were 
potential symptoms of ovarian cancer [49]. The 
Tanzanian study reported that less than half the 
respondents recognized the symptoms of cer-
vical cancer (prompted recognition): irregular 
vaginal bleeding (38% of respondents with cer-
vical cancer, 50.6% of respondents with other 
gynecological problems); postcoital bleeding 
(37.1 and 41.6%); postmenopausal bleeding 
(42.7 and 48.9%); and abnormal vaginal dis-
charge (39.3 and 48.9%). Correlates of late 
presentation included not knowing symptoms 
of cancer and lack of formal education (data 
not provided). It is noteworthy that the women 
diagnosed with cervical cancer reported lower 
levels of symptom awareness than the noncancer 
patients [52].
Colorectal cancer
Excluding skin, colorectal cancer is the third 
most commonly diagnosed cancer in women in 
the UK and the USA, accounting for approxi-
mately 12% of diagnoses in the UK [9] and 9% 
in the US [10], and the second most common in 
Australia [11]. It is, therefore, somewhat surpris-
ing that there is a limited body of research on 
knowledge of this cancer.
Four articles were identified that addressed 
women’s awareness of colorectal cancer (all four 
studies included male and female respondents; 
only the data from female respondents are 
reported), three were from the UK [44,57,58] and 
one from Australia [59]. Three of these reported 
on population surveys of colorectal cancer 
awareness (Table 5), with sample sizes rang-
ing from 526 [58] to 799 respondents [59]. One 
study used a recognition measure and found 
that, among their random sample of women 
aged 16 years and over, the majority agreed 
that blood in stools (92%), bleeding from the 
back passage (89%), change in bowel habit 
(83%), pain in the back passage (80%) and 
unexplained weight loss (79%) were potential 
symptoms of colorectal cancer, with a smaller 
proportion (54%) recognizing tiredness as a 
potential symptom [57].
The two population-based surveys that used 
recall measures found that blood in bowel 
movements was the most commonly recalled 
symptom (approximately one-third of those in 
the UK survey), with a smaller proportion iden-
tifying abdominal pain or a persistent change 
in bowel habits; even fewer identified the bowel 
not feeling empty after bowel motion, weight 
loss and mucus in stools as symptoms. In the 
Australian survey, 17% of female respondents 
and 53% of those in the UK survey could not 
name a single symptom of colorectal cancer. In 
the final study, only 47% of women surveyed 
while attending a breast or a colorectal clinic in 
the UK could name a symptom of bowel cancer.
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The Australian study did not report data on 
specific symptoms separately by gender; how-
ever, it is worthy to note that most studies found 
women to have higher levels of awareness than 
men [57–59]. Consistent with the findings for 
other types of cancers, knowledge of colorectal 
cancer symptoms was associated with higher 
levels of education [58,59], higher socioeconomic 
status, ethnicity (categorized as ‘white’ and 
‘other’, with the former associated with greater 
symptom knowledge) and knowing someone 
who was diagnosed with cancer [57].
Conclusion
The small body of literature on women’s aware-
ness of cancer symptoms, overall, suggests that 
the majority of women are able to recognize the 
more common cancer symptoms when provided 
with a list, but are unable to recall symptoms 
when asked to name warning signs of cancer 
(with the exception of a lump or thickening). 
This gap between recognition and recall was 
consistent for studies of specific cancer types. 
For example, a breast lump was the most con-
sistently identified symptom of breast cancer, 
with high levels of both recognition and recall; 
however, symptoms, such as a lump or swelling 
in the armpit, discharge from the nipple and 
a change in size or shape of the breast, were 
recognized but not recalled.
A consistent finding across cancer types was 
that symptom awareness was associated with 
higher educational attainment, higher income, 
and being Caucasian or a member of the domi-
nant cultural group. The association with age 
was varied, with levels of awareness of gen-
eral cancer symptoms appearing to be higher 
among older women, while awareness of breast 
and gynecological cancer symptoms specifically 
appeared to be lower among older women.
These f indings have important implica-
tions for both promoting engagement in can-
cer screening and implementing strategies to 
address late presentation for diagnosis and treat-
ment. In the former case, communication cam-
paigns to increase women’s awareness that many 
cancers have symptoms that can be detected by 
screening programs while the cancer is in its 
early stages (and thus require less invasive treat-
ment with a higher likelihood of survival) may 
increase women’s willingness to participate in 
these programs. In the latter case, increasing 
awareness of cancer symptoms at a population 
level may reduce patient delay in help-seeking by 
enabling women to recognize that their symp-
toms may represent a significant medical condi-
tion (in this case, cancer). Finally, the evident 
disparities in symptom awareness between those 
of higher and lower socioeconomic status and 
those who are and are not members of the domi-
nant cultural group suggest an urgent need for 
the development and dissemination of informa-
tion on cancer symptoms in a way that is under-
standable, accessible and relevant to women in 
lower socioeconomic groups, from culturally 
and linguistically diverse backgrounds and with 
lower levels of (health) literacy.
Limitations
The primary limitation of this study relates to 
the inclusion and exclusion criteria. For practi-
cal reasons, the articles included were limited to 
those written in English and accessible through 
the university’s database. Qualitative studies 
were also excluded; while such studies cannot 
be directly compared with the 52 quantitative 
papers that make up this review, they would 
likely provide rich descriptive data to contex-
tualize and expand on the findings. Finally, the 
lack of reporting of key data in a number of the 
articles – such as sampling methodologies, age 
of respondents, statistical information on find-
ings, among others – limited our ability to make 
direct comparisons and draw definitive conclu-
sions about differences between countries and 
samples.
Table 5. General population surveys: colorectal cancer.
Author (year) Country Sample 
size
Sampling method Survey method Age range 
(mean; years)
Response rate 
(%)
Ref.
Power et al. (2011) UK 731 Random location 
(quotas)
CAPI 16–50+ (N/S) N/S [57]
Yardley et al. 
(2000)
UK 526 Purposive (quotas) CATI 15–64+ (N/S) N/S† [58]
Cockburn et al. 
(2003)
Australia 799 Random CATI 40+ (N/S) 61.4 [59]
†Described as the majority of those called (a ratio of ~2.5:1) declined.
CAPI: Computer-assisted personal interview; CATI: Computer-assisted telephone interview; N/S: Not stated.
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Future perspective
An important consideration for researchers and 
clinicians is to determine which of these mea-
sures is the more important indicator in terms 
of seeking medical advice in response to a poten-
tial symptom. It may be that recognition of a 
symptom from a provided list indicates that a 
woman would equally recognize that symptom 
if she experienced it, but it is also possible that 
on experiencing a symptom, that same woman 
may not recall that it could be a symptom of 
cancer rather than a more benign condition. 
Future research could usefully address this issue 
in order to determine what form of awareness we 
should be aiming for. This is particularly impor-
tant given that the body of evidence – including 
studies reviewed in this paper and those beyond 
the scope of this review [60–62] – indicates that 
nonrecognition of symptoms is a predictor of 
delay in seeking diagnosis and treatment.
Breast cancer was by far the most studied 
type of cancer, with 34 articles meeting the 
inclusion criteria for the review. These stud-
ies also suggest that awareness of breast cancer 
symptoms is, across the countries and samples 
studied in the papers included in this review, 
considerably higher than awareness of gyneco-
logical and colorectal cancer symptoms. This 
could be a function of the nonspecific nature 
of the symptoms of some of these cancers (e.g., 
ovarian cancer). This position is supported by 
the relatively high recognition of nonsymp-
toms as being symptoms of ovarian cancer in 
the two studies that included these as control 
variables [50,51]. It is also possible that the low 
levels of symptom awareness are associated with 
the more hidden nature of these cancers due to 
social stigma and reluctance to discuss condi-
tions affecting bodily functions and intimate 
body parts [63–67]. However, given the lack of 
understanding of these cancers as well as a lack 
of awareness of the symptoms – for example, 
studies show that many women believe a Pap 
smear test is for ovarian cancer [50,68] – there is a 
clear need to increase women’s awareness of the 
symptoms of these cancers and to increase their 
willingness to discuss potential symptoms with 
their health professionals.
The topic of cancer awareness appears to 
have been most extensively researched in 
the UK (17 of the 52 papers included in the 
review), although we were able to identify and 
include studies from a range of countries. Future 
researchers should consider conducting repeated 
studies over time to track changes in awareness 
within, or ideally across, countries. One of the 
factors that limited the ability to compare across 
studies was the variation between researchers 
in the wording of symptoms and the inclusion/
exclusion of symptoms. This is no doubt asso-
ciated with the variations in the inclusion, and 
wording, of symptoms between countries and 
between agencies within countries – but it raises 
two important points for consideration. From 
a research perspective, this limits the ability 
to compare levels of awareness across samples 
and to assess the effectiveness of interventions. 
From a patient (and clinician) perspective, it 
makes the task of learning to recognize cancer 
symptoms even more difficult. In an age where 
Executive summary
Background
• Poor awareness of cancer symptoms has been associated with patient delay in help-seeking.
Cancer symptoms
• Few studies have been conducted; survey findings suggest recognition of symptoms are high, but recall is low.
Breast cancer
• There is high recognition and recall of breast lump as a symptom, but low awareness of many other symptoms.
• Low awareness of symptoms is associated with being older, less educated, lower income and ethnic minority.
Gynecological cancers
• There are far fewer research studies on gynecological cancers than breast cancer.
• There is a low awareness of symptoms, compounded by varied definitions and nonspecific nature of symptoms.
Colorectal cancer
• Similarly low levels of awareness of symptoms; blood in bowel movements is the most commonly recognized and recalled symptom.
Conclusion
• Inconsistent wording and inclusion of symptoms in studies makes comparison difficult.
• There is a need to determine whether recognition or recall of symptoms is the key awareness measure.
• A low level of awareness of symptoms of some cancers could be a function of the nonspecific nature of the symptoms, as well as the 
more ‘hidden’ nature of these cancers due to social stigma and reluctance to discuss conditions affecting bodily functions.
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the vast majority of the world’s population has 
ready access to the Internet, a person search-
ing for information on cancer symptoms is 
likely to come across an array of confusing and 
conflicting lists of symptoms.
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